Trial Profile
Pharmacokinetic interactions between macitentan and a combined oral contraceptive in healthy female subjects.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2016
Price :
$35
*
At a glance
- Drugs Macitentan (Primary) ; Ethinylestradiol/norethisterone
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions; Pharmacokinetics
- 23 Sep 2015 New trial record
- 18 Sep 2015 Results published in the Journal of Clinical Pharmacology.
- 02 Sep 2015 Results presented at the ESC Congress 2015: Annual Congress of the European Society of Cardiology